Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. Abb Vie Inc. Transaction History
Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P.
- $467 Million
- Q2 2024
A detailed history of Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. transactions in Abb Vie Inc. stock. As of the latest transaction made, Holt Capital Advisors, L.L.C. Dba Holt Capital Partners, L.P. holds 1,300 shares of ABBV stock, worth $253,227. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,300
Previous 1,484
12.4%
Holding current value
$253,227
Previous $270,000
17.78%
% of portfolio
0.05%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding ABBV
# of Institutions
3,694Shares Held
1.27BCall Options Held
13MPut Options Held
9.79M-
Vanguard Group Inc Valley Forge, PA171MShares$33.2 Billion0.57% of portfolio
-
Black Rock Inc. New York, NY136MShares$26.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA77.8MShares$15.2 Billion0.59% of portfolio
-
Jpmorgan Chase & CO New York, NY53.6MShares$10.4 Billion0.81% of portfolio
-
Capital International Investors Los Angeles, CA38.6MShares$7.52 Billion1.4% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $344B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...